Physician profile
Stephen Sitrin
NPI 1366440257
$376.58
in general payments reported to CMS, 2019-2025
13 companies · $81.57 in 2025
The $81.57 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.48 · 2020: $39.06 · 2021: $54.90 · 2022: $35.00 · 2023: $42.96 · 2024: $93.61 · 2025: $81.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $82.95 | 2022-2025 | Immunocap |
| Sanofi Pasteur INC. | $45.01 | 2022-2023 | |
| Pfizer INC. | $42.90 | 2020-2024 | |
| Cranial Technologies, INC | $37.89 | 2024-2025 | Doc Band |
| Kaleo, INC. | $33.29 | 2019-2021 | |
| Tris Pharma INC | $28.56 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.93 | 2021 | |
| Seqirus USA INC | $18.52 | 2024 | Flucelvax |
| Collegium Pharmaceutical, INC. | $17.30 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $14.67 | 2025 | Ycanth |
| Ultragenyx Pharmaceutical INC. | $14.27 | 2023 | |
| Merck Sharp & Dohme LLC | $12.46 | 2020 | |
| Corium, LLC | $3.83 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sitrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.